Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP183662.RAuDPpvcU629oIteTFbRCHJ0YBUh9Gw2rPDPmTruFo7NI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP183662.RAuDPpvcU629oIteTFbRCHJ0YBUh9Gw2rPDPmTruFo7NI130_assertion type Assertion NP183662.RAuDPpvcU629oIteTFbRCHJ0YBUh9Gw2rPDPmTruFo7NI130_head.
- NP183662.RAuDPpvcU629oIteTFbRCHJ0YBUh9Gw2rPDPmTruFo7NI130_assertion description "[Both MYO9B rs7259292 and HLA-DQ2 homozygosity increase the risk for RCD II and EATL to a similar extent when compared with uncomplicated CD patients (OR, 4.3; 95% CI, 1.9-9.8 and OR, 5.4; 95% CI, 3.0-9.6, respectively), but there was no evidence for any interaction between these 2 risk factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183662.RAuDPpvcU629oIteTFbRCHJ0YBUh9Gw2rPDPmTruFo7NI130_provenance.
- NP183662.RAuDPpvcU629oIteTFbRCHJ0YBUh9Gw2rPDPmTruFo7NI130_assertion evidence source_evidence_literature NP183662.RAuDPpvcU629oIteTFbRCHJ0YBUh9Gw2rPDPmTruFo7NI130_provenance.
- NP183662.RAuDPpvcU629oIteTFbRCHJ0YBUh9Gw2rPDPmTruFo7NI130_assertion SIO_000772 17967566 NP183662.RAuDPpvcU629oIteTFbRCHJ0YBUh9Gw2rPDPmTruFo7NI130_provenance.
- NP183662.RAuDPpvcU629oIteTFbRCHJ0YBUh9Gw2rPDPmTruFo7NI130_assertion wasDerivedFrom befree-20140225 NP183662.RAuDPpvcU629oIteTFbRCHJ0YBUh9Gw2rPDPmTruFo7NI130_provenance.
- NP183662.RAuDPpvcU629oIteTFbRCHJ0YBUh9Gw2rPDPmTruFo7NI130_assertion wasGeneratedBy ECO_0000203 NP183662.RAuDPpvcU629oIteTFbRCHJ0YBUh9Gw2rPDPmTruFo7NI130_provenance.